| ID |
http://id.who.int/icd/entity/1517015847 |
| Preferred Name |
Fièvre d'Ebola |
| Definitions |
A severe disease with high case fatality caused by infection with Ebola virus or a closely related virus. Ebola disease is typically characterized by acute onset of fever with non-specific symptoms/signs (e.g., abdominal pain, anorexia, fatigue, malaise, myalgia, sore throat) usually followed several days later by nausea, vomiting, diarrhea, and occasionally a variable rash. Hiccups may occur. Severe illness may include hemorrhagic manifestations (e.g., bleeding from puncture sites, ecchymoses, petechiae, visceral effusions), encephalopathy, shock/hypotension, multi-organ failure, spontaneous abortion in infected pregnant women. Common laboratory findings include thrombocytopenia, elevated transaminase concentrations, electrolyte abnormalities, and signs of renal dysfunction. Individuals who recover may experience prolonged sequelae (e.g., arthralgia, neurocognitive dysfunction, uveitis sometimes followed by cataract formation), and clinical and subclinical persistent infection may occur in immune-privileged compartments (e.g., CNS, eyes, testes). Person-to-person transmission occurs by direct contact with blood, other bodily fluids, organs, or contaminated surfaces and materials with risk beginning at the onset of clinical signs and increasing with disease severity. Family members, sexual contacts, healthcare providers, and participants in burial ceremonies with direct contact with the deceased are at particular risk. The incubation period typically is 7–11 days (range ≈2–21 days). |
| Type |
http://www.w3.org/2002/07/owl#Class |
| comment | A severe disease with high case fatality caused by infection with Ebola virus or a closely related virus. Ebola disease is typically characterized by acute onset of fever with non-specific symptoms/signs (e.g., abdominal pain, anorexia, fatigue, malaise, myalgia, sore throat) usually followed several days later by nausea, vomiting, diarrhea, and occasionally a variable rash. Hiccups may occur. Severe illness may include hemorrhagic manifestations (e.g., bleeding from puncture sites, ecchymoses, petechiae, visceral effusions), encephalopathy, shock/hypotension, multi-organ failure, spontaneous abortion in infected pregnant women. Common laboratory findings include thrombocytopenia, elevated transaminase concentrations, electrolyte abnormalities, and signs of renal dysfunction. Individuals who recover may experience prolonged sequelae (e.g., arthralgia, neurocognitive dysfunction, uveitis sometimes followed by cataract formation), and clinical and subclinical persistent infection may occur in immune-privileged compartments (e.g., CNS, eyes, testes). Person-to-person transmission occurs by direct contact with blood, other bodily fluids, organs, or contaminated surfaces and materials with risk beginning at the onset of clinical signs and increasing with disease severity. Family members, sexual contacts, healthcare providers, and participants in burial ceremonies with direct contact with the deceased are at particular risk. The incubation period typically is 7–11 days (range ≈2–21 days). μια σοβαρή ασθένεια με μεγάλο χρονικό διάστημα θανατηφόρα που προκαλείται από μόλυνση με ιό του ιού ή μια στενά συνδεδεμένη παρθένω. η νόσος της εμβοές χαρακτηρίζεται συνήθως από την οξεία εμφάνιση του πυρετού με μη συγκεκριμένα συμπτώματα / σημάδια (π.χ., πόνο στην κοιλιακή χώρα, ανορεξία, κόπωση, δυσφορία, μυαλγία, πονόλαιμο) συνήθως ακολουθούμενη αρκετές ημέρες αργότερα από nausea, έμετος, διάρροια, και κατά καιρούς μια μεταβλητή παλινδρό. μπορεί να εμφανιστεί. une maladie grave avec un risque élevé de létalité à la suite d'une infection par le virus ebola ou un virus étroitement apparenté. la maladie d'ebola se caractérise généralement par l'apparition aiguë de la fièvre avec des symptômes ou des signes non spécifiques (p. ex., douleurs abdominales, anorexie, fatigue, malaise, myalgie, mal de gorge) habituellement suivie plusieurs jours plus tard de nausées, de vomissements, de diarrhée et parfois d'une éruption variable. des cas de séquelles peuvent se manifester. les maladies graves peuvent comprendre des manifestations hémorragiques (p. ex., saignement des points de ponction, ecchymoses, pétéchies, effusions viscérales), encéphalopathie, état de choc / hypotension, défaillance de plusieurs organes, avortement spontané chez les femmes enceintes infectées. les résultats de laboratoire courants comprennent la thrombocytopénie, nausée |
| IRI | |
| icd11Chapter | 01 |
| broaderTransitive | http://id.who.int/icd/entity/1238540753 http://id.who.int/icd/entity/774338239 |
| prefLabel | Fièvre d'Ebola |
| mms | |
| browserUrl | NA |
| narrowerTransitive | http://id.who.int/icd/entity/1950399694 http://id.who.int/icd/entity/816737725 http://id.who.int/icd/entity/792755706 http://id.who.int/icd/entity/239620085 |
| icd11Code | 1D60.0Z 1D60.0 1D60.0Y |
| label | choroba eboli Ebola-Krankheit Fièvre d'Ebola Ebola disease ebola ασθένεια |
| subClassOf | http://id.who.int/icd/entity/1238540753 http://id.who.int/icd/entity/774338239 |
| Delete | Subject | Subject Sort | Archive Sort | Author | Type | Created | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No notes to display | ||||||||||||